Pharmaceutical Executive June 4, 2024
Ravinder Singh

Delivering better patient outcomes hinges on innovation and adaptability.

We are at the crossroads of transformative change in the ever-evolving life sciences landscape. The journey ahead promises not only technological advancements and groundbreaking innovations but also a fundamental shift toward patient-centric care.

For instance, the FDA recently announced a ‘Patient-Focused Drug Development’1 (PFDD) approach to systematically integrate patients’ experiences, perspectives, needs and priorities into the drug development and evaluation process. Why? By leveraging their personal experiences, patients play a unique and invaluable role in enhancing the understanding of the therapeutic context for drug development and evaluation. The insight from this data is invaluable.

Moreover, patients are well-informed and looking for hyper-personalized experiences that are secure, reliable and transparent — factors...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Big Data, Biotechnology, Patient / Consumer, Pharma / Biotech, Technology
Related Articles:
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
A Biologist Explains The ‘Weird’ Habits Of People Who Live To 100+ Years Old
U.S. Health Care Spending Reaches $4.9 Trillion
Medicaid spending on weight loss, diabetes drugs up 500% since 2019: 5 numbers to know
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Share This Article